HONG KONG - A year after the first cases of the A/H1N1 influenza surfaced in Mexico and the U.S., the World Health Organization is facing accusations that it overreacted to the threat and pushed too hard for a rapidly available vaccine
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The company’s incoming CEO Mike Doustdar has promised greater agility, competitiveness and execution, but investors are yet to be convinced.
Bayer continues to keep faith in its pharmaceuticals business despite a plethora of problems for the wider group with job cuts, continued debt concerns and ongoing glyphosate litigation claims.
Shares of the Palo Alta, CA-based firm fell as Attruby sales missed elevated investor expectations in the second full quarter since its launch.
